Overview

Impact of Lidocaine Administration on Postoperative Complications During Lung Resection Surgery

Status:
Completed
Trial end date:
2021-07-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to analyze the impact of the intravenous (IV) or paravertebral (PV) lidocaine administration during the intraoperative period of lung resection surgery on the appearance of postoperative complications. We design a randomized, controlled and blinded study to be performed in 153 patients with 3 arms: 1) Lidocaine IV + PV saline 2) saline IV + PV lidocaine, 3) remifentanil IV + PV saline. Perioperative analysis of inflammatory biomarkers in bronchoalveolar lavage and serum. Follow-up of the postoperative course, especially the appearance of postoperative complications according to the revised Clavien-Dindo classification for thoracic surgery, as well as other relevant clinical results.
Phase:
Phase 4
Details
Lead Sponsor:
Francisco Andres de la Gala
Collaborator:
Instituto de Salud Carlos III
Treatments:
Lidocaine
Piperidine
Remifentanil